Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Clinical Handbook of Psychotropic Drugs -

Clinical Handbook of Psychotropic Drugs

Buch | Softcover
IV, 480 Seiten
2025 | 26. Aufl.
Hogrefe Publishing (Verlag)
978-0-88937-668-7 (ISBN)
CHF 118,90 inkl. MwSt
  • Noch nicht erschienen (ca. April 2025)
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
The classic reference to psychotropic medications for psychiatrists, psychologists, physicians, pharmacists, and nurses, packed with the latest drugs, completely revised sections, and much more.
Quick and comprehensive information on psychotropic drugs for adults.Accurate and up-to-dateComparison charts help decision-makingIcons and full colorAvailable both in print and onlineDownloadable patient information sheetsMore about this bookThe ###ITALIC#TEXT[Clinical Handbook of Psychotropic Drugs]### has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.Independent, unbiased, up-to-datePacked with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions...) for a quick overview of treatment optionsSuccinct, bulleted information on all classes of medication: on- and off-label indications, (US FDA, Health Canada), recommended dosages, US and Canadian trade names, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more - all you need to know for each class of drugPotential interactions and side effects summarized in comparison chartsWith instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seekThis book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.Clearly written patient information sheets can be downloaded as printable PDF files from the Hogrefe website after registrationNew in this editionAntidepressants chapter revised extensively and includes new sections on the selective serotonin-1A agonist gepirone and difficult-to-treat depressionAntipsychotics chapter includes a new section on the muscarinic agonist/antagonist combination (Xanomeline/trospium chloride), a novel treatment that does not block D2 dopamine receptors. Major revisions to TGA Dosing and PharmacokineticsDrugs for ADHD comparison table expandedDrugs of Abuse chapter has been revised extensively and includes a new section on Psychedelics and Dissociative DrugsNew formulations and trade names include: Abilifi Asimtufii (aripiprazole extended-release 2-monthly injection), Azstarys (serdexmethylphenidate/dexmethylphenidate capsules), CAMCEVI (leuprolide 6-month slow-release SC depot injection), Drizalma Sprinkle (duloxetine capsules), Eldepryl (selegiline tablets and capsules), Esprontia (topiramate oral solution), Exxua (gepirone extended-release tablets), Ketalar (ketamine hydrochloride injection), Lybalvi (olanzapine/samidorphan tablets), Onyda (clonidine extended-release suspension), Relexii (methylphenidate extended-release tablets), Secuado (asenapine transdermal patch), Zurzuvae (zuranolone capsules)Do you want print and online? Deal with adults and children? Then combine CHPD publications and save. Click here for more information.
Erscheint lt. Verlag 30.4.2025
Zusatzinfo 38 printable PDF patient information sheets
Sprache englisch
Maße 279 x 216 mm
Gewicht 1 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Medizinische Fachgebiete Psychiatrie / Psychotherapie
Medizin / Pharmazie Pharmazie PTA / PKA
Schlagworte Handbook • Psychopharmacology • Psychotropic drugs
ISBN-10 0-88937-668-9 / 0889376689
ISBN-13 978-0-88937-668-7 / 9780889376687
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich